No Relief From Bloated Swiss Drug Prices


(MENAFN- Swissinfo) The price difference for medicines between Switzerland and other countries has further increased. In Switzerland, patent-protected medicines cost on average 8.9% more than in other European countries. A year ago, the price difference was 5.4%.

This content was published on May 31, 2024 - 11:54 2 minutes

People abroad now pay 14.3% less for off-patent original preparations. A year ago, the price difference was only 10.8%, as the health insurance association Santésuisse and the association of research-based Pharmaceutical companies Interpharma announced on Friday.

As has been the case for years, the price differences are particularly marked for generics and biosimilars, they said. According to the data, generics are 45.3% cheaper abroad, while biosimilars cost 29.9% less. The foreign price comparison compared current factory prices of medicines with those in other European countries in the period from January to April 2024.

+ Read more: Drug pricing: Swiss expert calls for more transparency

Immediate measures
expected

Santésuisse Director Verena Nold pointed out that people who buy medicines in Switzerland continue to pay more than abroad, and that price differences have even increased. The association therefore expects the federal government to take immediate action, particularly regarding generics, to bring excessive prices down to the European level. Overall, more than CHF1.3 billion ($1.4 billion) could be saved annually on medicines without any loss of quality.

Interpharma Managing Director René Buholzer stated in the press release that the prices of patent-protected medicines will be brought to the European level. At constant exchange rates, the price difference to other countries would only be two percentage points. In addition, drug prices are to fall steadily. He emphasised that a one-sided focus on costs by politicians is increasingly jeopardising patients' access to innovative medicines.

Adapted from German by DeepL/kc

This news story has been written and carefully fact-checked by an external editorial team. At SWI swissinfo we select the most relevant news for an international audience and use automatic translation tools such as DeepL to translate it into English. Providing you with automatically translated news gives us the time to write more in-depth articles.

If you want to know more about how we work, have a look here , and if you have feedback on this news story please write to ... .

External Content Your subscription could not be saved. Please try again. Almost finished... We need to confirm your email address. To complete the subscription process, please click the link in the email we just sent you. Daily news

Get the most important news from Switzerland in your inbox.

Daily

Email

The SBC Privacy Policy provides additional information on how your data is processed.

I consent to the use of my data for the SWI swissinfo newsletter.

News More Interest in Geneva Motor Show sputters

This content was published on May 31, 2024 Though a large audience attended the 2024 edition, next year's show is in question, due to poor signals from the market.

Read more: Interest in Geneva Motor Show sputters More Switzerland to intensify border checks during sporting events

This content was published on May 31, 2024 In the context of events including the European Football Championships and the summer Olympics, border security will be increased.

Read more: Switzerland to intensify border checks during sporting events More Integration of Credit Suisse into UBS now complete

This content was published on May 31, 2024 Credit Suisse AG was formally integrated into UBS AG on Friday, with the former being subsequently deleted from Canton Zurich's commercial register.

Read more: Integration of Credit Suisse into UBS now complete More Pharma firm Takeda to cut up to 120 Swiss jobs

This content was published on May 31, 2024 Up to 10% of employees at its Opfikon location will be let go as part of an efficiency programme, the company announced.

Read more: Pharma firm Takeda to cut up to 120 Swiss jobs More China's participation in Ukraine peace summit in doubt

This content was published on May 31, 2024 A lack of participation by China would be seen as a setback for the conference planned to take place in June.

Read more: China's participation in Ukraine peace summit in doubt More Swiss cities vie to host next Eurovision

This content was published on May 31, 2024 The list of cities in the running as well as the requirements they need to meet have not been disclosed. A decision is to be made by the end of August.

Read more: Swiss cities vie to host next Eurovision More Fighter jets to use Swiss motorway as runway

This content was published on May 31, 2024 Eight jets will be involved in the exercise, for which a stretch of motorway will be closed for up to 36 hours.

Read more: Fighter jets to use Swiss motorway as runway More Salt intake in Switzerland too high owing to ready meals

This content was published on May 30, 2024 Switzerland's average salt consumption is around 75% above the recommended five grams per day, according to a study.

Read more: Salt intake in Switzerland too high owing to ready meals More UBS fined CHF50,000 for suspected money-laundering negligence

This content was published on May 30, 2024 Switzerland's finance ministry has fined UBS bank CHF50,000 after employees allegedly failed to report red flags of money laundering over several years.

Read more: UBS fined CHF50,000 for suspected money-laundering negligence More Switzerland received more than 400 extradition requests last year

This content was published on May 30, 2024 Switzerland received 430 requests for the extradition of criminals last year, an increase of over a quarter compared to 2022.

Read more: Switzerland received more than 400 extradition requests last year

In compliance with the JTI standards

More: SWI swissinfo certified by the Journalism Trust Initiative

You can find an overview of ongoing debates with our journalists here . Please join us!

If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at ... .

MENAFN31052024000210011054ID1108281931


Swissinfo

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.